These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7768074

  • 1. Stereoselective disposition of carvedilol is determined by CYP2D6.
    Zhou HH, Wood AJ.
    Clin Pharmacol Ther; 1995 May; 57(5):518-24. PubMed ID: 7768074
    [Abstract] [Full Text] [Related]

  • 2. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.
    Marandi T, Dahl ML, Kiivet RA, Rägo L, Sjöqvist F.
    Pharmacol Toxicol; 1996 May; 78(5):303-7. PubMed ID: 8737964
    [Abstract] [Full Text] [Related]

  • 3. Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism.
    Dahl ML, Tybring G, Elwin CE, Alm C, Andreasson K, Gyllenpalm M, Bertilsson L.
    Clin Pharmacol Ther; 1994 Aug; 56(2):176-83. PubMed ID: 8062494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
    Adedoyin A, Arns PA, Richards WO, Wilkinson GR, Branch RA.
    Clin Pharmacol Ther; 1998 Jul; 64(1):8-17. PubMed ID: 9695714
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine.
    Brynne N, Dalén P, Alván G, Bertilsson L, Gabrielsson J.
    Clin Pharmacol Ther; 1998 May; 63(5):529-39. PubMed ID: 9630826
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T, Dayer P.
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
    Edeki TI, He H, Wood AJ.
    JAMA; 1986 May; 274(20):1611-3. PubMed ID: 7474246
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.